Glenmede Trust’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $125K | Buy |
56,796
+17,173
| +43% | +$37.8K | ﹤0.01% | 1259 |
|
|
2024
Q4 | $60.6K | Buy |
39,623
+7,720
| +24% | +$11.8K | ﹤0.01% | 1324 |
|
|
2024
Q3 | $63.5K | Buy |
31,903
+10,578
| +50% | +$21.1K | ﹤0.01% | 1311 |
|
|
2024
Q2 | $74.6K | Buy |
21,325
+5,135
| +32% | +$18K | ﹤0.01% | 1265 |
|
|
2024
Q1 | $44.8K | Buy |
16,190
+4,317
| +36% | +$12K | ﹤0.01% | 1273 |
|
|
2023
Q4 | $20.2K | Buy |
+11,873
| New | +$20.2K | ﹤0.01% | 1257 |
|